Regentis Biomaterials (RGNT) Debt Ratio (2024 - 2025)
Regentis Biomaterials' (RGNT) quarterly Debt Ratio came in at 0.16 in Q4 2025, down 86.78% year-on-year from 1.19 in Q4 2024, and down 86.78% on a QoQ basis from 1.19 in Q4 2024.
Regentis Biomaterials (RGNT) Debt Ratio (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has 2 years of Debt Ratio data on file, last reported at 0.16 in Q4 2025.
- On a quarterly basis, Debt Ratio fell 86.78% year-over-year to 0.16 in Q4 2025; TTM through Dec 2025 was 0.16, a 86.78% decrease from a year earlier, with the FY2025 full-year figure at 0.16, down 86.78% from the prior year.
- Debt Ratio for Q4 2025 stood at 0.16, down from 1.19 in the prior quarter.
- Over the last five years, Debt Ratio for RGNT reached as high as 1.19 in Q4 2024 and fell as low as 0.16 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 0.13 |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 0.34 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 0.32 |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 0.08 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 0.05 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 0.20 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 0.36 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Regentis Biomaterials | 1.10 Mn | -6.28 Mn | - | 0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.16 |
| Dec 31, 2024 | 1.19 |